Jushi Holdings (CSE: JUSH) appears to be focused on vertically integrating its operations as a means of capturing more margin. The firm this morning announced that it has acquired a dispensary in Nevada, its first in the state, following its acquisition of Franklin Bioscience, a cultivator and processor in the state, earlier this year.
Currently branded as The Apothecarium, the dispensary itself is located in Las Vegas, however it is located off the strip in the downtown region. The retail location currently is qualified for the sale of both medical and recreational cannabis sales in the state.
Given that the acquisition is for a single dispensary, no terms were provided by the company in regards to financial consideration paid for the asset.
The acquisition marks the fourth state in which the company will have vertically integrated operations, following the states of Massachusetts, Virginia and Pennsylvania. The purchase follows the US$91.2 million acquisition of Nature’s Remedy in Massachusetts, which consisted of two dispensaries and a cultivation and production facility.
Jushi Holdings last traded at $5.41 on the CSE.
Information for this briefing was found via Sedar and Jushi. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.